| Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of … F Lattanzio, S Abu-Rumeileh, A Franceschini, H Kai, G Amore, I Poggiolini, ... Acta neuropathologica 133, 559-578, 2017 | 175 | 2017 |
| Cerebrospinal fluid real‐time quaking‐induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study LI McGuire, A Poleggi, I Poggiolini, S Suardi, K Grznarova, S Shi, B de Vil, ... Annals of neurology 80 (1), 160-165, 2016 | 136 | 2016 |
| Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies I Poggiolini, V Gupta, M Lawton, S Lee, A El-Turabi, A Querejeta-Coma, ... Brain 145 (2), 584-595, 2022 | 130 | 2022 |
| α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity SS Ghanem, NK Majbour, NN Vaikath, MT Ardah, D Erskine, NM Jensen, ... Proceedings of the National Academy of Sciences 119 (15), e2109617119, 2022 | 117 | 2022 |
| Prion protein misfolding, strains, and neurotoxicity: an update from studies on mammalian prions I Poggiolini, D Saverioni, P Parchi International journal of cell biology 2013 (1), 910314, 2013 | 79 | 2013 |
| Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease C Ruffmann, N Bengoa‐Vergniory, I Poggiolini, D Ritchie, MT Hu, ... Neuropathology and applied neurobiology 44 (7), 722-736, 2018 | 64 | 2018 |
| Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse S Benvegnù, I Poggiolini, G Legname Journal of Comparative Neurology 518 (11), 1879-1891, 2010 | 50 | 2010 |
| Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions D Saverioni, S Notari, S Capellari, I Poggiolini, A Giese, HA Kretzschmar, ... Journal of Biological Chemistry 288 (39), 27972-27985, 2013 | 46 | 2013 |
| Human‐specific transcriptome of ventral and dorsal midbrain dopamine neurons J Monzón‐Sandoval, I Poggiolini, T Ilmer, R Wade‐Martins, C Webber, ... Annals of Neurology 87 (6), 853-868, 2020 | 31 | 2020 |
| RT-QuIC using C-terminally truncated α-synuclein forms detects differences in seeding propensity of different brain regions from synucleinopathies I Poggiolini, D Erskine, NN Vaikath, J Ponraj, S Mansour, CM Morris, ... Biomolecules 11 (6), 820, 2021 | 17 | 2021 |
| Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study M Abdi, E Aliyev, B Trost, M Kohailan, W Aamer, N Syed, R Shaath, ... Genome Medicine 15 (1), 81, 2023 | 11 | 2023 |
| Inhibition of α-synuclein seeding-dependent aggregation by ssDNA aptamers specific to C-terminally truncated α-synuclein fibrils I Hmila, IP Sudhakaran, SS Ghanem, NN Vaikath, I Poggiolini, ... ACS Chemical Neuroscience 13 (23), 3330-3341, 2022 | 10 | 2022 |
| CSF RT-QuIC is a robust and reliable test for sporadic CJD: An international study LI McGuire, A Poleggi, I Poggiolini, S Suardi, K Grznarova, S Shi, B de Vil, ... Ann Neurol 80 (1), 160-165, 2016 | 7 | 2016 |
| Mapping the prion protein distribution in marsupials: Insights from comparing opossum with mouse cns I Poggiolini, G Legname PloS one 7 (11), e50370, 2012 | 6 | 2012 |
| A recessive variant in SIM2 in a child with complex craniofacial anomalies and global developmental delay AA Al-Kurbi, SI Da'as, W Aamer, N Krishnamoorthy, I Poggiolini, ... European Journal of Medical Genetics 65 (4), 104455, 2022 | 2 | 2022 |
| Colonic alpha-synuclein: a potential diagnostic biomarker in Parkinson's disease C Ruffmann, I Poggiolini, M Hu, L Parkkinen NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 42, 51-51, 2016 | 2 | 2016 |
| Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease D Hrabos, I Poggiolini, L Civitelli, E Galli, C Esapa, M Saarma, P Lindholm, ... Neuropathology and Applied Neurobiology 50 (4), e12999, 2024 | 1 | 2024 |
| PHASE I-II FIRST-IN-MAN CLINICAL TRIAL OF INTRAPUTAMENAL CDNF IN PARKINSON’S DISEASE: EXPLORATORY FLUID-BASED BIOMARKER ENDPOINTS OF THE 12-MONTH TREATMENT PERIOD HJ Huttunen, S Booms, NK Majbour, HB Abdesselem, OM El-Agnaf, ... | 1 | 2021 |
| Developmental prion protein expression in eutherian and methaterian mammalian central nervous system I Poggiolini, G Legname Landesbioscience, 2012 | 1 | 2012 |
| Alpha-Synuclein (ASN) paraffin-embedded tissue (PET) blots in the brain and periphery I Poggiolini, C Ruffmann, M Hu, L Parkkinen NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 42, 12-12, 2016 | | 2016 |